Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2025. The report specifically details a transaction in the company's own shares executed on September 3, 2025, and announced on September 4, 2025.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics. It focuses exclusively on share repurchase activity under the second tranche of a buyback programme announced on July 31, 2025.
| Metric | Value |
|---|---|
| Shares Purchased | 354,000 |
| Highest Price Paid (p) | 370.30 |
| Lowest Price Paid (p) | 363.40 |
| Volume Weighted Average Price (p) | 366.13 |
| Registered Share Capital | 8,955,967,411 ordinary shares |
| Treasury Shares Held | 3,880,205 |
| Voting Shares Outstanding | 8,952,087,206 |
Material Changes
The primary material change reported is the reduction of the company's share count due to the cancellation of 354,000 ordinary shares. This transaction was part of an ongoing share buyback programme. The filing does not provide comparative financial data against prior periods.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the share buyback. The filing includes standard legal disclaimers stating the announcement does not constitute an offer or solicitation of securities. No specific guidance, risks, or contingencies regarding future operations or financial performance are detailed in this specific report.
Key Facts for Investor Verification
- Verify the total number of shares repurchased under the second tranche of the buyback programme since its announcement on July 31, 2025.
- Confirm the current market price of Haleon shares relative to the average purchase price of 366.13 pence.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link for granular execution details.
- Check subsequent filings for updates on the remaining capacity of the share buyback programme.